Tag: Vascular access
Access Vascular highlights new midline catheter data at AVA 2024
Access Vascular Inc (AVI) today announced findings from a proactive device evaluation showing a significant reduction in complications with a midline catheter made with...
Endothelial tight junctions and their role in vascular access
Nikos Giannikas and Panos Kitrou (Patras, Greece) write together about the role that endothelial tight junctions play in vascular access, evidence from previous studies,...
Vascular Therapies completes enrolment in the ACCESS 2 study
Vascular Therapies has today announced completion of enrolment in the ACCESS 2 trial, a Phase III prospective randomised, multicentre clinical study of Sirogen for the...
Xeltis receives IDE approval from US FDA for haemodialysis vascular access...
Xeltis has announced that it has gained approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) submission to...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation at the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK) of five-year data from the IN.PACT AV Access study...
Aperto® DCB: A breakthrough in prolonging dialysis access survival
This advertorial is sponsored by Cardionovum.
Cardionovum’s CE-marked Aperto drug-coated balloon (DCB) is, according to expert opinion and a growing evidence base, spearheading a revolution...
Novel peripherally-inserted catheter found superior to conventional options
Medical device company Access Vascular has announced the publication of a peer-reviewed study of its HydroPICC peripherally inserted central catheter (PICC) in the Journal of...
Xeltis presents six-month first-in-human data on aXess graft
Xeltis has presented “highly-encouraging” six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society (VAS;...
Patient and staff education among 10 key priorities identified in vascular...
A list of 10 key research priorities intended to help standardise vascular access research were delivered to attendees at this year’s Vascular Access Society...
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
Vascular News’ top 10 most popular stories of June 2022
Coverage of this year's Leipzig Interventional Course (LINC; 6–9 June, Leipzig, Germany) and Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM; 15–18 June,...
Nipro to bring Cronus high-pressure PTA balloon catheter to USA
Nipro Medical Corporation is set to introduce its second-generation Cronus high-pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter to the US market.
Cronus HP is...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
Ellipsys™ Vascular Access System provides consistently great outcomes for AV fistula...
Alexandros Mallios (Paris, France) and Robert Shahverdyan (Hamburg, Germany) talk to Vascular News about some of the benefits of the Ellipsys™ Vascular Access System...
Amplifi vein dilation system demonstrates “encouraging” clinical results in haemodialysis access
Artio Medical has announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium...
Results from first-in-human study of Amplifi vein dilation system presented at...
Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at Vascular Interventional Advances (VIVA) 2021 (5–7 October...
Stable incidence and survival of AVFs in Danish dialysis population in...
Despite an older dialysis population, the proportion and survival of arteriovenous fistulas (AVFs) in Danish dialysis patients has not changed over a 39-year period....
Oversized balloon angioplasty technique safe and effective for AV fistula maturation
A retrospective analysis published in the Journal of Vascular Access (JVA) has shown that the oversized balloon angioplasty technique to assist arteriovenous (AV) fistula...
Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...
Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...
New standardised reporting system suggests arteriovenous graft infections may be less...
“Using an objective system that discriminates between aetiology and outcome allows a more complete, objective understanding of relative infection risks and outcomes for arteriovenous...
LINC 2021: Positive first-time data presented for IN.PACT AV DCB and...
New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) support the use of drug-coated balloons (DCBs)...
Artio Medical announces successful first human use of the Amplifi vein...
Artio Medical recently announced that it has successfully completed the first human use of its Amplifi vein dilation system. The first clinical procedure was...
Largest US nephrology group is first in Illinois to offer Ellipsys...
Nephrology Associates of Northern Illinois and Indiana (NANI), the largest nephrology group in the USA, is the first practice in Illinois to adopt the Ellipsys vascular access system (Avenu Medical, now...
Network meta-analysis finds DCB angioplasty “significantly superior” to plain balloon angioplasty...
A recent network meta-analysis shows that, in failing arteriovenous fistulas (AVFs) with outflow stenosis, drug-coated balloon (DCB) angioplasty is “significantly superior” to plain balloon...
COVID-related hypercoagulability linked to elevated malfunction rate in temporary haemodialysis catheters
Hypercoagulability in COVID-19 patients leads to an increase in the malfunction rate of temporary haemodialysis catheters—but heparin locking of the catheters is linked to...
Risk of ischaemic steal syndrome and patency rate comparable for tapered...
In their recent systematic review and meta-analysis, Venkata Sai Jasty (University of Arizona, Tuscon, USA) and colleagues found that the risk of ischaemic steal...
New protocol helps identify best venipuncture site for femoral access
RaFeVA (Rapid Femoral Vein Assessment), a new protocol, is a rapid and effective tool for the systematic ultrasound evaluation of the veins in the...
Older age and diabetes mellitus identified as risk factors for poor...
Different risk factors affect patency between vascular access construction and the first percutaneous transluminal angioplasty, Mahoko Yoshida (Hiroshima University Hospital, Hiroshima, Japan) and colleagues...
Clinician survey reveals significant variation in ultrasound-guided PIV insertion
A new survey among vascular access (VA) and emergency department (ED) clinicians has revealed significant levels of variation in ultrasound-guided peripheral IV (UGPIV) practices...
Teleflex announces expanded indications for the Arrow EZ-IO intraosseous vascular access...
Teleflex has announced it has received 510(k) clearance from the US Food and Drug Administration to expand the indications for use of the Arrow...
Dialysis access needs to be a priority in the COVID-19 era
Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...
Patient-specific computation model may improve AVF maturation rates
The results of a randomised controlled trial—the Shunt simulation study—show that a new patient-specific computation model accurately calculated postoperative access flow. As flow is...
Study shows advantages of Ellipsys system in dialysis access creation
A new study shows significant benefits of the Ellipsys vascular access system (Avenu Medical) in easily and safely creating durable vascular access for end-stage...
Surfacer system IDE study results published in Journal of Vascular Access
Bluegrass Vascular Technologies has announced the publication of the results of its prospective, multicentre SAVE-US (Surfacer system to facilitate access in venous occlusions—United States)...
CX 2020 LIVE: Vascular Access session showcases new technologies, while debate...
The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking...
Published real-world experience demonstrates VasQ External Support improves outcomes when adopted...
Robert Shahverdyan, head of the Vascular Access Center at Asklepios Klinik Barmbek, Hamburg, Germany, has recently published a retrospective analysis of his first 32...
IVUS during haemodialysis access “aids device selection and adequacy of treatment”
Narayan Karunanithy outlines the benefits of intravascular ultrasound (IVUS) during haemodialysis access intervention.
Thoracic central veins include intra-thoracic segments of the internal jugular, subclavian, brachiocephalic...
“A yearly hub for innovation in vascular access”: i-VAS 2019 and...
Following the 2019 International Vascular Access Symposium (i-VAS 2019; 13 September, Paris, France), current president Alexandros Mallios talks to Vascular News about his highlights...
Bluegrass Vascular announce publication of positive clinical results Surfacer system published
Bluegrass Vascular Technologies (Bluegrass Vascular) has announced the publication of positive results associated with the clinical use of the Surfacer Inside-Out access catheter system...
“More creative solutions” needed for end-stage vascular access patients
Nicholas (Nick) Inston calls for “more creative solutions” to vascular access challenges, commending interventional radiologists’ innovative reputation as instrumental to increasing the number of...
Laminate Medical Technologies announces enrolment of first forearm patients in pivotal...
Laminate Medical Technologies has announced the enrolment of their first forearm fistula patients in their US pivotal trial of the VasQ device. VasQ is...
SAVE-US pivotal trial completes enrolment and has positive clinical results
The SAVE-US (Surfacer system to facilitate access in venous occlusions—United States) pivotal trial has completed enrollment. The SAVE-US trial is evaluating the safety and...
The impact of paclitaxel concerns on vascular access
At the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK), there was a section of the programme on drug-coated balloon trial updates which...
The role of surveillance in thrombosis treatment
As part of the CX Vascular Access Masterclass on Wednesday, Colin Deane (London, UK) considered the role of surveillance in thrombosis, asking whether there...
Comparing and contrasting surgically-created AVFs with those made by endovascular means
Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...
Retrospective study finds 97% success rate with Surfacer Inside-Out access catheter
The Surfacer Inside-Out Access Catheter System (Bluegrass Vascular) has demonstrated positive commercial use, consistently achieving central venous access in patients with upper body occlusions....
Minimising arteriovenous graft infections and preserving vascular access using partial graft...
The findings of a new retrospective review carried out by Suh Min Kim (Dongguk University Ilsan Hospital, Goyang, Korea) and colleagues that aimed to...
Flow Forward Medical exceeds US$8 million investments, awarded grant from NIH
Flow Forward Medical, a medical device company focused on improving outcomes for haemodialysis patients through the rapid creation of high-quality vascular access sites, has...
The dialysis access landscape in 2018: Challenges, advances and future directions
Guidelines of the European Society for Vascular Surgery1 give an overview of the current best evidence for vascular access for dialysis. Although these guidelines...
AngioDynamics provides update on vascular access business
AngioDynamics has provided a corporate update and acknowledged a recent, favourable US District Court ruling that impacts its vascular access business.
A press release states...
Japanese study investigates new device for accurate haemodialysis catheter placement
Researchers at Okayama University report in The Journal of Vascular Access the use of a supporting device for accurately placing haemodialysis catheters in dialysis...
Arteriovenous thigh graft access could be an option for haemodialysis patients
A study published recently in the Journal of Vascular Access has indicated that the use of arteriovenous thigh graft access is viable as an...
EchoNous Vein receives FDA approval
EchoNous Vein (EchoNous), an ultrasound-based tool designed specifically for nurses to improve peripheral IV catheter placements, has received US Food and Drug Administration (FDA)...
BD acquires TVA Medical, makers of everlinQ endoAVF System
BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...
FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation
Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...
Humacyte appoints Jeffrey Lawson as president and CEO
Humacyte, an innovator in biotechnology and regenerative medicine, has announced that Jeffrey Lawson has been appointed president and chief executive officer. The former chairman...
Bluegrass Vascular’s SAVE-US catheter access device trial begins enrolment
Bluegrass Vascular Technologies has announced the enrolment of its first patients in the SAVE-US (Surfacer System to Facilitate Access in Venous Occlusions–United States) pivotal trial.
The SAVE-US trial is...
First patients enrolled in US pivotal trial of the VasQ device
The first patients have been enrolled in the US FDA pivotal study of VasQ (Laminate Medical Technologies), an implanted blood vessel external support device...
Access Vascular secures US$3.7m in financing
Access Vascular has announced US$3.7m in funding from individual investors and angelMD, an investment platform and marketplace connecting innovative medical start-ups, physicians, investors and industry partners....
Vonapanitase associated with increased fistula survival and haemodialysis use
Data from the PATENCY-1 trial indicate that the application of vonapanitase (Proteon Therapeutics) at the time of fistula surgery is associated with increased fistula...
First four Spanish VasQ cases completed
Laminate Medical has announced the success of the first four Spanish clinical cases using the VasQ device.
The cases were performed by Gaspar Mestres at...
Laminate receives IDE approval from FDA to initiate study of the...
Laminate Medical Technologies, an Israeli biomedical start-up developing VasQ, an implanted blood vessel external support device for patients requiring arteriovenous fistula as vascular access for...
Humacyte’s Humacyl receives US FDA expedited review designation
The US Food and Drug Administration (FDA) has granted Humacyte’s Humacyl investigational human acellular vessel (HAV) Regenerative Medicine Advanced Therapy (RMAT) designation.
This designation means...
Flow Forward reports Arteriovenous Fistula Eligibility system data
Flow Forward Medical has announced the completion of a preclinical study and a computational fluid dynamics study supporting continued development of the company's Arteriovenous...
Achieving haemostasis in radial artery access
The VasoStat (Forge Medical) is a haemostasis device designed for radial, brachial and transpedal procedures. The device is placed over the puncture site to...
Bluegrass Vascular announces CE mark approval and successful commercial use of...
Bluegrass Vascular Technologies has received CE mark approval and is launching limited commercial sale of its Surfacer Inside-Out access catheter system. The Surfacer system...
AV Medical announces initial Chameleon PTA balloon catheter US experience
AV Medical has commenced cases in the USA with its Chameleon angioplasty balloon catheter.
With its Supervision design, an AV Medical press release says...
